Ramipril and the development of diabetes. Yusuf S, Gerstein H, Hoogwerf B, Pogue J, Bosch J, Wolffenbuttel BH, Zinman B; HOPE Study Investigators. Canadian Cardiovascular Collaboration Project Office, Hamilton General Hospital, 237 Barton St East, Hamilton, Ontario, Canada L8L 2X2. yusufs@mcmaster.ca CONTEXT: Type 2 diabetes is a growing clinical and public health problem. Preventive efforts related to lifestyle modification are not always successful; therefore, alternative prevention strategies need to be studied. OBJECTIVE: To investigate the effectiveness of ramipril, an angiotensin-converting enzyme inhibitor, in preventing diabetes among high-risk persons. DESIGN, SETTING, AND PARTICIPANTS: The randomized, controlled Heart Outcomes Pre...
Purpose: The aim was to investigate the use of cardioprotective drug therapies (aspirin or other ant...
Purpose: The aim was to investigate the use of cardioprotective drug therapies (aspirin or other ant...
Abstract Background Recent clinical trials reported conflicting results on the reduction of new-onse...
Ramipril and the development of diabetes.Yusuf S, Gerstein H, Hoogwerf B, Pogue J, Bosch J, Wolffenb...
Ramipril and the development of diabetes.Yusuf S, Gerstein H, Hoogwerf B, Pogue J, Bosch J, Wolffenb...
Background: Previous studies have suggested that blockade of the renin-angiotensin system may preven...
mellitus is a strong risk factor for cardiovascular and renal disease. We investigated whether the a...
Background: Previous studies have suggested that blockade of the renin-angiotensin system may preven...
Aims/hypothesis: Diabetes is a rapidly rising independent risk factor for atherosclerosis and seriou...
BACKGROUND Diabetes (T2DM) is a worldwide medical and social emergency in the westernized societies....
AH and diabetes mellitus are comorbid diseases and are interconnected by general pathophysiological ...
OBJECTIVE: To describe the design of the HOPE (Heart Outcomes Prevention Evaluation) Study.DESIGN: D...
CONTEXT: Type 2 diabetes is emerging as a major health problem, which tends to cluster with hyperten...
CONTEXT: Type 2 diabetes is emerging as a major health problem, which tends to cluster with hyperten...
CONTEXT: Type 2 diabetes is emerging as a major health problem, which tends to cluster with hyperten...
Purpose: The aim was to investigate the use of cardioprotective drug therapies (aspirin or other ant...
Purpose: The aim was to investigate the use of cardioprotective drug therapies (aspirin or other ant...
Abstract Background Recent clinical trials reported conflicting results on the reduction of new-onse...
Ramipril and the development of diabetes.Yusuf S, Gerstein H, Hoogwerf B, Pogue J, Bosch J, Wolffenb...
Ramipril and the development of diabetes.Yusuf S, Gerstein H, Hoogwerf B, Pogue J, Bosch J, Wolffenb...
Background: Previous studies have suggested that blockade of the renin-angiotensin system may preven...
mellitus is a strong risk factor for cardiovascular and renal disease. We investigated whether the a...
Background: Previous studies have suggested that blockade of the renin-angiotensin system may preven...
Aims/hypothesis: Diabetes is a rapidly rising independent risk factor for atherosclerosis and seriou...
BACKGROUND Diabetes (T2DM) is a worldwide medical and social emergency in the westernized societies....
AH and diabetes mellitus are comorbid diseases and are interconnected by general pathophysiological ...
OBJECTIVE: To describe the design of the HOPE (Heart Outcomes Prevention Evaluation) Study.DESIGN: D...
CONTEXT: Type 2 diabetes is emerging as a major health problem, which tends to cluster with hyperten...
CONTEXT: Type 2 diabetes is emerging as a major health problem, which tends to cluster with hyperten...
CONTEXT: Type 2 diabetes is emerging as a major health problem, which tends to cluster with hyperten...
Purpose: The aim was to investigate the use of cardioprotective drug therapies (aspirin or other ant...
Purpose: The aim was to investigate the use of cardioprotective drug therapies (aspirin or other ant...
Abstract Background Recent clinical trials reported conflicting results on the reduction of new-onse...